Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chondrosarcoma, Mesenchymal × Trabectedin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 37 Leiomyosarcoma 12 Liposarcoma 10 Sarcoma, Ewing 4 Neoplasms 4 Liposarcoma, Myxoid 4 Sarcoma, Synovial 3 Rhabdomyosarcoma 3 Histiocytoma, Malignant Fibrous 3 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neurofibrosarcoma 2 Malignant mesenchymal tumor 2 Ichthyosis, X-Linked 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2 Fibrosarcoma 2 Bone Neoplasms 2 Wilms Tumor 1 Solitary Fibrous Tumors 1 Sarcoma, Endometrial Stromal 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leiomyosarcoma Uterus 1 Hemangioendothelioma 1

Interventions

regorafenib 1 pazopanib 1 Trabectedin 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Pharmacogenomic Testing 1 Ifosfamide 1 HhAntag691 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305548 2026-03-27

ISG-MCS

Italian Sarcoma Group

Phase 2 Recruiting

Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡